Cargando…

Complement Activation Levels Are Related to Disease Stage in AMD

PURPOSE: To study the levels of complement activation in different disease stages of AMD and the influence of genetic polymorphisms in complement genes. METHODS: We included 797 patients with AMD and 945 controls from the European Genetic Database. Patients were grouped into five AMD stages: early A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Heesterbeek, Thomas J., Lechanteur, Yara T. E., Lorés-Motta, Laura, Schick, Tina, Daha, Mohamed R., Altay, Lebriz, Liakopoulos, Sandra, Smailhodzic, Dzenita, den Hollander, Anneke I., Hoyng, Carel B., de Jong, Eiko K., Klevering, B. Jeroen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Association for Research in Vision and Ophthalmology 2020
Materias:	Retina
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7401663/ https://www.ncbi.nlm.nih.gov/pubmed/32176267 http://dx.doi.org/10.1167/iovs.61.3.18

Ejemplares similares

A Novel Complotype Combination Associates with Age-Related Macular Degeneration and High Complement Activation Levels in vivo
por: Paun, Constantin C., et al.
Publicado: (2016)

Risk factors for progression of age‐related macular degeneration
por: Heesterbeek, Thomas J, et al.
Publicado: (2020)

Impact of the Common Genetic Associations of Age-Related Macular Degeneration upon Systemic Complement Component C3d Levels
por: Ristau, Tina, et al.
Publicado: (2014)

Genetic and environmental risk factors for extramacular drusen
por: Altay, Lebriz, et al.
Publicado: (2020)

Phenotypic Expression of CFH Rare Variants in Age-Related Macular Degeneration Patients in the Coimbra Eye Study
por: Farinha, Cláudia, et al.
Publicado: (2022)

Zinc Supplementation Inhibits Complement Activation in Age-Related Macular Degeneration
por: Smailhodzic, Dzenita, et al.
Publicado: (2014)

Analysis of Risk Alleles and Complement Activation Levels in Familial and Non-Familial Age-Related Macular Degeneration
por: Saksens, Nicole T. M., et al.
Publicado: (2016)

Genetics of Unilateral and Bilateral Age-Related Macular Degeneration Severity Stages
por: Schick, Tina, et al.
Publicado: (2016)

Corrigendum to “Nutritional Risk Factors for Age-Related Macular Degeneration”
por: Ersoy, Lebriz, et al.
Publicado: (2016)

Nutritional Risk Factors for Age-Related Macular Degeneration
por: Ersoy, Lebriz, et al.
Publicado: (2014)

The Effect of Genetic Variants Associated With Age-Related Macular Degeneration Varies With Age
por: Schick, Tina, et al.
Publicado: (2020)

Evaluating the Occurrence of Rare Variants in the Complement Factor H Gene in Patients With Early-Onset Drusen Maculopathy
por: de Breuk, Anita, et al.
Publicado: (2021)

GWAS study using DNA pooling strategy identifies association of variant rs4910623 in OR52B4 gene with anti-VEGF treatment response in age-related macular degeneration
por: Riaz, Moeen, et al.
Publicado: (2016)

A genetic variant in NRP1 is associated with worse response to ranibizumab treatment in neovascular age-related macular degeneration
por: Lorés-Motta, Laura, et al.
Publicado: (2016)

Alteration of retinal layers in healthy subjects over 60 years of age until nonagenarians
por: Altay, Lebriz, et al.
Publicado: (2017)

The Impact of Diabetic Retinopathy on the Choriocapillaris in Neovascular AMD
por: Viggiano, Pasquale, et al.
Publicado: (2023)

Association analysis of genetic and environmental risk factors in the cuticular drusen subtype of age-related macular degeneration
por: van de Ven, Johannes P.H., et al.
Publicado: (2012)

Association of plasma trace element levels with neovascular age-related macular degeneration
por: Heesterbeek, Thomas J., et al.
Publicado: (2020)

Exploring the Relationship Between Multilayered Choroidal Neovascularization and Choriocapillaris Flow Deficits in AMD
por: Nesper, Peter L., et al.
Publicado: (2021)

Spatial Dissociation of Subretinal Drusenoid Deposits and Impaired Scotopic and Mesopic Sensitivity in AMD
por: Zhang, Yuhua, et al.
Publicado: (2022)

Relationship Between Drusen Height and OCT Biomarkers of Atrophy in Non-Neovascular AMD
por: Au, Adrian, et al.
Publicado: (2022)

Aqueous Fluid Transcriptome Profiling Differentiates Between Non-Neovascular and Neovascular AMD
por: Kaidonis, Georgia, et al.
Publicado: (2023)

Hyperreflective foci on optical coherence tomography associate with treatment outcome for anti-VEGF in patients with diabetic macular edema
por: Schreur, Vivian, et al.
Publicado: (2018)

Genetic Risk in Families with Age-Related Macular Degeneration
por: de Breuk, Anita, et al.
Publicado: (2021)

Fluorescence Lifetimes and Spectra of RPE and Sub-RPE Deposits in Histology of Control and AMD Eyes
por: Schultz, Rowena, et al.
Publicado: (2020)

The Association of Fluid Volatility With Subretinal Hyperreflective Material and Ellipsoid Zone Integrity in Neovascular AMD
por: Ehlers, Justis P., et al.
Publicado: (2022)

Topographical Analysis of the Choriocapillaris Reperfusion After Loading Anti-VEGF Therapy in Neovascular AMD
por: Viggiano, Pasquale, et al.
Publicado: (2022)

Associations with visual acuity outcomes after 12 months of treatment in 9401 eyes with neovascular AMD
por: Relton, SD, et al.
Publicado: (2022)

Semi-Quantitative Multiplex Profiling of the Complement System Identifies Associations of Complement Proteins with Genetic Variants and Metabolites in Age-Related Macular Degeneration
por: Acar, I. Erkin, et al.
Publicado: (2021)

Development and validation of a novel prognostic model for predicting AMD progression using longitudinal fundus images
por: Bridge, Joshua, et al.
Publicado: (2020)

Capturing the Transition From Intermediate to Neovascular AMD: Longitudinal Inner Retinal Thinning and Factors Associated With Neuronal Loss
por: Borrelli, Enrico, et al.
Publicado: (2023)

Retinal Vessel Functionality Is Linked With ARMS2 A69S and CFH Y402H Polymorphisms and Choroidal Status in AMD Patients
por: Krytkowska, Elżbieta, et al.
Publicado: (2021)

Systematic review of efficacy and meta-analysis of safety of ranibizumab biosimilars relative to reference ranibizumab anti-VEGF therapy for nAMD treatment
por: Hatamnejad, Amin, et al.
Publicado: (2023)

Genetic screening for macular dystrophies in patients clinically diagnosed with dry age‐related macular degeneration
por: Kersten, Eveline, et al.
Publicado: (2018)

Evaluation of Local Rod and Cone Function in Stargardt Disease
por: Stingl, Krunoslav, et al.
Publicado: (2022)

Genetic and environmental risk factors for reticular pseudodrusen in the EUGENDA study
por: Altay, Lebriz, et al.
Publicado: (2021)

AAV Gene Augmentation of Truncated Complement Factor H Differentially Rescues Ocular Complement Dysregulation in a Mouse Model
por: Grigsby, Daniel, et al.
Publicado: (2023)

Complement Activation in the Vitreous of Patients With Proliferative Diabetic Retinopathy
por: Mandava, Nikhil, et al.
Publicado: (2020)

Repeatability of Quantitative Autofluorescence Imaging in a Multicenter Study Involving Patients With Recessive Stargardt Disease 1
por: Dhooge, Patty P. A., et al.
Publicado: (2023)

Systemic complement levels in patients with age-related macular degeneration carrying rare or low-frequency variants in the CFH gene
por: de Jong, Sarah, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_39sdtr6tjh2sv8getseerj8pm9